Employers › Quest Diagnostics Clinical Laboratories
Recordkeeping fees per participant · The Quest Diagnostics Profit Sharing Plan · plan year 2024
$44.77
Higher than 75% of the 790 plans over $1B that report it.
= $2,087,000 / 46,617
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250826142507NAL0008787841001, received 2025-08-26
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250826142507NAL0008787841001, received 2025-08-26
Percentiles compare this plan with the Schedule H plans over $1B in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-08-26.
Administrative expenses excluding investment management, per participant
$45.88
Higher than 52% of the 1,045 plans over $1B that report it.
= $2,139,000 / 46,617
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250826142507NAL0008787841001, received 2025-08-26
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250826142507NAL0008787841001, received 2025-08-26
Administrative expenses per participant
$48.76
Higher than 29% of the 1,076 plans over $1B that report it.
= $2,273,000 / 46,617
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250826142507NAL0008787841001, received 2025-08-26
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250826142507NAL0008787841001, received 2025-08-26
Administrative expenses as a share of assets
0.041%
Higher than 44% of the 1,076 plans over $1B that report it.
= $2,273,000 / $5,555,146,000
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250826142507NAL0008787841001, received 2025-08-26
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250826142507NAL0008787841001, received 2025-08-26
Employer contributions per participant
$2,159
Higher than 21% of the 1,135 plans over $1B that report it.
= $100,667,000 / 46,617
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250826142507NAL0008787841001, received 2025-08-26
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250826142507NAL0008787841001, received 2025-08-26
Employer share of total contributions
30.1%
Higher than 39% of the 1,135 plans over $1B that report it.
= $100,667,000 / $334,867,000
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250826142507NAL0008787841001, received 2025-08-26
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250826142507NAL0008787841001, received 2025-08-26
Plan terms are not published in public filings.
2E profit-sharing · 2F ERISA 404(c) plan · 2H partially participant-directed · 2I · 2J 401(k) feature · 2K 401(m) arrangement · 2O ESOP-related feature · 3H controlled-group sponsor · 2X · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250826142507NAL0008787841001, received 2025-08-26
| Field | Value | Source |
|---|---|---|
| Plan sponsor | QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Plan name | THE QUEST DIAGNOSTICS PROFIT SHARING PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Sponsor EIN / plan number | 38-2084239 / 333 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Plan type | multiple-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Sponsor location | SECAUCUS, NJ | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Industry (business code) | 621510, Health care and social assistance | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Filing received | 2025-08-26 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Participants, beginning of year | 61,319 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Active participants | 48,596 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Participants, end of year | 62,875 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Participants with an account balance | 46,617 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Total assets, beginning of year | $5,126,995,000 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Total assets, end of year | $5,555,146,000 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Net assets, end of year | $5,553,770,000 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Total income | $1,095,226,000 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Net income | $427,625,000 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Employer contributions | $100,667,000 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Participant contributions | $191,222,000 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Other contributions (incl. rollovers) | $42,978,000 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Total contributions | $334,867,000 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Benefit payments | $665,328,000 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Total expenses (incl. benefit payments) | $667,601,000 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Total administrative expenses | $2,273,000 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Recordkeeping fees | $2,087,000 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Investment advisory and management fees | $134,000 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Administrative expenses excluding investment management | $2,139,000 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Held in common/collective trusts | $4,699,307,000 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Held in mutual funds | $204,410,000 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250826142507NAL0008787841001, received 2025-08-26 |
| Independent auditor | GRANT THORNTON LLP | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250826142507NAL0008787841001, received 2025-08-26 |
Position = column in the DOL layout for form year 2024. Filing 20250826142507NAL0008787841001, received 2025-08-26.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| FIDELITY INVESTMENTS INSTITUTIONALrecordkeeper | NONE | 15 Recordkeeping and information management; 37 Participant loan processing; 50 Direct payment from the plan; 64 Recordkeeping fees | $2,087,000 | yes |
| AON INVESTMENTS USA INC | NONE | 27 Investment advisory (plan); 50 Direct payment from the plan | $134,000 | no |
| RISK STRATEIES CONSULTING, INC. | NONE | 16 Consulting (general); 50 Direct payment from the plan | $43,000 | no |
| SEYFARTH SHAW LLP | NONE | 29 Legal; 50 Direct payment from the plan | $10,000 | no |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250826142507NAL0008787841001, received 2025-08-26.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $5,126,995,000 | $5,555,146,000 | 8.4% |
| Participants with a balance | 46,044 | 46,617 | 1.2% |
| Administrative expenses | $1,731,000 | $2,273,000 | 31.3% |
| Recordkeeping fees per participant | $26.06 | $44.77 | 71.8% |
| Employer contributions | $98,792,000 | $100,667,000 | 1.9% |
Prior filing 20241010144655NAL0020361521001, received 2024-10-10; the plan years are contiguous.
Sponsor name as filed: QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC.; SEC registrant: QUEST DIAGNOSTICS CLINICAL LABORATORIES INC /DE/ (CIK 1092331, matched by EIN).